Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Food additive approvals: risks vs benefits

M H Davidson1

  • 1Chicago Center for Clinical Research and Preventive Medicine, Chicago, Illinois 60610, USA.

Regulatory Toxicology and Pharmacology : RTP
|February 1, 1996
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk.

Diabetes, obesity & metabolism·2011
Same author

Effectiveness of statins in Medicare-eligible patients and patients < 65 years using clinical practice data.

International journal of clinical practice·2007
Same author

Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia.

International journal of clinical practice·2004
Same author

Perspectives: Benefits of a new, nonsystemic lipid-lowering agent: the clinician's perspective.

Preventive cardiology·2002
Same author

Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial.

Mayo Clinic proceedings·2001
Same author

Treatment of the elderly with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors: focus on drug interactions.

Journal of cardiovascular pharmacology and therapeutics·2001